Isolation of cDNA clones for human beta-glucocerebrosidase using the lambda gt11 expression system. 1984

E I Ginns, and P V Choudary, and B M Martin, and S Winfield, and B Stubblefield, and J Mayor, and D Merkle-Lehman, and G J Murray, and L A Bowers, and J A Barranger

Two cDNA clones (lambda GC-1 and lambda GC-2) for human beta-glucocerebrosidase [EC 3.2.1.45] have been isolated from a human hepatoma library in lambda gt11 by immunological screening using monospecific polyclonal antibody for beta-glucocerebrosidase. Restriction endonuclease mapping indicates that these clones are probably identical in size, each with a 1900 bp insert. The 50 kDa size of the insert-encoded polypeptide produced by these clones in fusion with beta-galactosidase of lambda gt11 in E. coli BNN103 is consistent with the size of the nascent form of beta-glucocerebrosidase. These fusion proteins are shown by Western blotting to react with antibody to beta-glucocerebrosidase. Amino acid sequence deduced from the nucleotide sequence of the insert ir pGC-1 is identical to known amino acid sequence of beta-glucocerebrosidase, and thus, confirms that the clones are specific for beta-glucocerebrosidase.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D010582 Bacteriophage lambda A temperate inducible phage and type species of the genus lambda-like viruses, in the family SIPHOVIRIDAE. Its natural host is E. coli K12. Its VIRION contains linear double-stranded DNA with single-stranded 12-base 5' sticky ends. The DNA circularizes on infection. Coliphage lambda,Enterobacteria phage lambda,Phage lambda,lambda Phage
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004587 Electrophoresis, Agar Gel Electrophoresis in which agar or agarose gel is used as the diffusion medium. Electrophoresis, Agarose Gel,Agar Gel Electrophoresis,Agarose Gel Electrophoresis,Gel Electrophoresis, Agar,Gel Electrophoresis, Agarose
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D005959 Glucosidases Enzymes that hydrolyze O-glucosyl-compounds. (Enzyme Nomenclature, 1992) EC 3.2.1.-. Glucosidase
D005962 Glucosylceramidase A glycosidase that hydrolyzes a glucosylceramide to yield free ceramide plus glucose. Deficiency of this enzyme leads to abnormally high concentrations of glucosylceramide in the brain in GAUCHER DISEASE. EC 3.2.1.45. Glucocerebrosidase,Acid beta-Glucosidase,Glucocerebroside beta-Glucosidase,Glucosyl Ceramidase,Glucosylceramide beta-Glucosidase,Glucosylsphingosine Glucosyl Hydrolase,beta-Glucocerebrosidase,Acid beta Glucosidase,Ceramidase, Glucosyl,Glucocerebroside beta Glucosidase,Glucosyl Hydrolase, Glucosylsphingosine,Glucosylceramide beta Glucosidase,Hydrolase, Glucosylsphingosine Glucosyl,beta Glucocerebrosidase,beta-Glucosidase, Acid,beta-Glucosidase, Glucocerebroside,beta-Glucosidase, Glucosylceramide
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas

Related Publications

E I Ginns, and P V Choudary, and B M Martin, and S Winfield, and B Stubblefield, and J Mayor, and D Merkle-Lehman, and G J Murray, and L A Bowers, and J A Barranger
May 1987, Biochemical and biophysical research communications,
E I Ginns, and P V Choudary, and B M Martin, and S Winfield, and B Stubblefield, and J Mayor, and D Merkle-Lehman, and G J Murray, and L A Bowers, and J A Barranger
June 1989, Brain research. Molecular brain research,
E I Ginns, and P V Choudary, and B M Martin, and S Winfield, and B Stubblefield, and J Mayor, and D Merkle-Lehman, and G J Murray, and L A Bowers, and J A Barranger
January 1991, Methods in enzymology,
E I Ginns, and P V Choudary, and B M Martin, and S Winfield, and B Stubblefield, and J Mayor, and D Merkle-Lehman, and G J Murray, and L A Bowers, and J A Barranger
November 1990, BioTechniques,
E I Ginns, and P V Choudary, and B M Martin, and S Winfield, and B Stubblefield, and J Mayor, and D Merkle-Lehman, and G J Murray, and L A Bowers, and J A Barranger
January 1993, Methods in enzymology,
E I Ginns, and P V Choudary, and B M Martin, and S Winfield, and B Stubblefield, and J Mayor, and D Merkle-Lehman, and G J Murray, and L A Bowers, and J A Barranger
April 1990, BioTechniques,
E I Ginns, and P V Choudary, and B M Martin, and S Winfield, and B Stubblefield, and J Mayor, and D Merkle-Lehman, and G J Murray, and L A Bowers, and J A Barranger
January 1987, Methods in enzymology,
E I Ginns, and P V Choudary, and B M Martin, and S Winfield, and B Stubblefield, and J Mayor, and D Merkle-Lehman, and G J Murray, and L A Bowers, and J A Barranger
February 1990, BioTechniques,
E I Ginns, and P V Choudary, and B M Martin, and S Winfield, and B Stubblefield, and J Mayor, and D Merkle-Lehman, and G J Murray, and L A Bowers, and J A Barranger
January 1988, Biochemistry,
E I Ginns, and P V Choudary, and B M Martin, and S Winfield, and B Stubblefield, and J Mayor, and D Merkle-Lehman, and G J Murray, and L A Bowers, and J A Barranger
February 1985, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!